Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Clinical studies have reported that the psychedelic lysergic acid diethylamide (LSD) enhances empathy and social behavior (SB) in humans, but its mechanism of action remains elusive. Using a multidisciplinary approach including in vivo electrophysiology, optogenetics, behavioral paradigms, and molecular biology, the effects of LSD on SB and glutamatergic neurotransmission in the medial prefrontal cortex (mPFC) were studied in male mice. Acute LSD (30 μg/kg) injection failed to increase SB. However, repeated LSD (30 μg/kg, once a day, for 7 days) administration promotes SB, without eliciting antidepressant/anxiolytic-like effects. Optogenetic inhibition of mPFC excitatory neurons dramatically inhibits social interaction and nullifies the prosocial effect of LSD. LSD potentiates the α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) and 5-HT 2A , but not N -methyl-D-aspartate (NMDA) and 5-HT 1A , synaptic responses in the mPFC and increases the phosphorylation of the serine-threonine protein kinases Akt and mTOR. In conditional knockout mice lacking Raptor (one of the structural components of the mTORC1 complex) in excitatory glutamatergic neurons ( Raptor f/f :Camk2alpha-Cre ), the prosocial effects of LSD and the potentiation of 5-HT 2A /AMPA synaptic responses were nullified, demonstrating that LSD requires the integrity of mTORC1 in excitatory neurons to promote SB. Conversely, in knockout mice lacking Raptor in GABAergic neurons of the mPFC ( Raptor f/f :Gad2-Cre ), LSD promotes SB. These results indicate that LSD selectively enhances SB by potentiating mPFC excitatory transmission through 5-HT 2A /AMPA receptors and mTOR signaling. The activation of 5-HT 2A /AMPA/mTORC1 in the mPFC by psychedelic drugs should be explored for the treatment of mental diseases with SB impairments such as autism spectrum disorder and social anxiety disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Though the primary molecular targets of ketamine and serotonergic psychedelics are distinct, their downstream pharmacology overlaps, requiring AMPA receptor, TrkB, and mTOR activation to elicit changes in neuronal structure and function (135–137, 148, 153, 154).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [154]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
Self-citationmTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · cited 3×
“Indeed,, these effects are prevented by the intracranial administration of rapamycin (24).”
Impairment of social and moral behavior related to early damage in human prefrontal cortex
Anderson, S. W., Bechara, A., Damasio, H., Tranel, D., & Damasio, A. R. (1999) · Nature Neuroscience · doi:10.1038/14833 · Cited by 1,539 · cited 3×
“The prefrontal cortex (PFC) exerts a pivotal role in the modulation of SB in mammals (1).”
Psychedelics promote structural and functional neural plasticity
Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.022 · Cited by 1,207
Mechanisms of ketamine action as an antidepressant
Zanos, P., & Gould, T. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.255 · Cited by 1,127 · cited 1×
“The mTOR pathway is activated by several psychoactive drugs, including the hallucinogen ketamine (23, 24) and selective serotonin reuptake inhibitor (SSRI) antidepressants (25).”
González-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925 · cited 1×
“Layer V pyramidal glutamatergic neurons are the main output of the mPFC, and it is through these neurons that LSD exerts its behavioral effects, as observed in previous pharmacological and brain imaging studies (33, 34).”
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723
mTORC1 controls fasting-induced ketogenesis and its modulation by ageing
Sengupta, S., Peterson, T. R., Laplante, M., Oh, S., & Sabatini, D. M. (2010) · Nature · doi:10.1038/nature09584 · Cited by 646
The complex relation between morality and empathy
Decety, J., & Cowell, J. M. (2014) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2014.04.008 · Cited by 602
The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity
Shahbazian, D., Roux, P. P., Mieulet, V., Cohen, M. S., Raught, B., Taunton, J., Hershey, J. W., Blenis, J., Pende, M., & Sonenberg, N. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601166 · Cited by 531
Self-citationSerotonin model of schizophrenia: emerging role of glutamate mechanisms
Aghajanian, G. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00046-6 · Cited by 529 · cited 1×
“…in humans have shown that the effects of LSD on SB are mediated by mPFC 5-HT 2A receptors (16, 17), and that the activation of postsynaptic cortical 5-HT 2A receptors increases glutamate release in the synaptic cleft, an effect that can be reversed by AMPA antagonists like LY293558 (11, 18).”
Autism-related deficits via dysregulated eIF4E-dependent translational control
Gkogkas, C. G., Khoutorsky, A., Ran, I., Rampakakis, E., Nevarko, T., Weatherill, D. B., Vasuta, C., Yee, S., Truitt, M., Dallaire, P., et al. (2013) · Nature · doi:10.1038/nature11628 · Cited by 522 · cited 1×
“Furthermore, dysregulation of mTORC1 signaling is implicated in social deficit disorders (12, 26, 27).”
Self-citationPardo, C. A., & Eberhart, C. G. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00102.x · Cited by 514
AGHAJANIAN, G. K., & MAREK, G. J. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00051-8 · Cited by 514
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Schmid, Y., Enzler, F., Gasser, P., Grouzmann, E., Preller, K. H., Vollenweider, F. X., Brenneisen, R., Müller, F., Borgwardt, S., & Liechti, M. E. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.015 · Cited by 411
Preller, K. H., Herdener, M., Pokorny, T., Planzer, A., Kraehenmann, R., Stämpfli, P., Liechti, M. E., Seifritz, E., & Vollenweider, F. X. (2017) · Current Biology · doi:10.1016/j.cub.2016.12.030 · Cited by 402
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Rickli, A., Moning, O. D., Hoener, M. C., & Liechti, M. E. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.05.001 · Cited by 379
mTOR complexes in neurodevelopmental and neuropsychiatric disorders
Costa-Mattioli, M., & Monteggia, L. M. (2013) · Nature Neuroscience · doi:10.1038/nn.3546 · Cited by 367 · cited 3×
“Furthermore, dysregulation of mTORC1 signaling is implicated in social deficit disorders (12, 26, 27).”
Chattopadhyaya, B., Di Cristo, G., Wu, C. Z., Knott, G., Kuhlman, S., Fu, Y., Palmiter, R. D., & Huang, Z. J. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.015 · Cited by 327
mTORC1-mediated translational elongation limits intestinal tumour initiation and growth
Faller, W. J., Jackson, T. J., Knight, J. R. P., Ridgway, R. A., Jamieson, T., Karim, S. A., Jones, C., Radulescu, S., Huels, D. J., Myant, K. B., et al. (2015) · Nature · doi:10.1038/nature13896 · Cited by 302
Self-citationThiagarajan, T. C., Piedras-Renteria, E. S., & Tsien, R. W. (2002) · Neuron · doi:10.1016/s0896-6273(02)01049-8 · Cited by 288
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Dolder, P. C., Schmid, Y., Müller, F., Borgwardt, S., & Liechti, M. E. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.82 · Cited by 247 · cited 2×
“For example, the acute administration of lysergic acid diethylamide (LSD) in humans produces feelings of happiness, trust, closeness to others, and enhanced emotional empathy (4), while promoting positive mood changes, altruistic/positive social effects, and well-being/ life satisfaction (5).”
Long-lasting subjective effects of LSD in normal subjects.
Schmid, Y., & Liechti, M. E. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4733-3 · Cited by 232
Halberstadt, A. L., & Geyer, M. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3006-z · Cited by 213
Hibicke, M., Landry, A. N., Kramer, H. M., Talman, Z. K., & Nichols, C. D. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00493 · Cited by 205 · cited 1×
“Unlike ketamine, we found that LSD does not have antidepressant properties in naïve mice, in contrast to recent work showing that LSD at 150 μg/kg produced antidepressant-like effects 5 wk after a single administration (35).”
The medial prefrontal cortex mediates social event knowledge
Krueger, F., Barbey, A. K., & Grafman, J. (2009) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2008.12.005 · Cited by 174
Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of Autism
Huber, K. M., Klann, E., Costa-Mattioli, M., & Zukin, R. S. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2656-15.2015 · Cited by 167 · cited 1×
“Furthermore, dysregulation of mTORC1 signaling is implicated in social deficit disorders (12, 26, 27).”
Psychedelic Drugs in Biomedicine
Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.08.003 · Cited by 155 · cited 1×
“LSD is a partial agonist of the serotonin 5-HT 2A receptor (6), but also displays affinity for the 5-HT 1A receptor (7 – 9).”
Bambico, F. R., Cassano, T., Domínguez-López, S., Katz, N., Walker, C. D., Piomelli, D., & Gobbi, G. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.80 · Cited by 154
Self-citationMarek, G. J., & Aghajanian, G. K. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20792-3 · Cited by 152
d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology
De Gregorio, D., Comai, S., Posa, L., & Gobbi, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111953 · Cited by 123
Self-citationDistinct neural mechanisms for the prosocial and rewarding properties of MDMA
Heifets, B. D., Salgado, J. S., Taylor, M. D., Hoerbelt, P., Cardozo Pinto, D. F., Steinberg, E. E., Walsh, J. J., Sze, J. Y., & Malenka, R. C. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw6435 · Cited by 120
De Gregorio, D., Posa, L., Ochoa-Sanchez, R., McLaughlin, R., Maione, S., Comai, S., & Gobbi, G. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.08.022 · Cited by 110
Self-citationSerotonin 2C receptor antagonists induce fast-onset antidepressant effects
Opal, M. D., Klenotich, S. C., Morais, M., Bessa, J., Winkle, J., Doukas, D., Kay, L. J., Sousa, N., & Dulawa, S. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.144 · Cited by 103
Gregorio, D. D., Enns, J. P., Núñez, N. A., Posa, L., & Gobbi, G. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.07.008 · Cited by 103
Self-citationGobbi, G., & Janiri, L. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0317-3 · Cited by 95
Self-citationChronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway
Ibarra‐Lecue, I., Mollinedo-Gajate, I., Meana, J. J., Callado, L. F., Díez-Alarcia, R., & Urigüen, L. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0076-y · Cited by 92
Sigmon, S. C., Tidey, J. W., Badger, G. J., & Higgins, S. T. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1416-z · Cited by 73
Preller, K. H., Schilbach, L., Pokorny, T., Flemming, J., Seifritz, E., & Vollenweider, F. X. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.1939-17.2018 · Cited by 71
Serotonergic hallucinogens as translational models relevant to schizophrenia
Halberstadt, A. L., & Geyer, M. A. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000722 · Cited by 67
Gresch, P. J., Smith, R. L., Barrett, R. J., & Sanders-Bush, E. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300711 · Cited by 62
Huang, W.-H., Wang, D. C., Allen, W. E., Klope, M., Hu, H., Shamloo, M., & Luo, L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806796115 · Cited by 39 · cited 1×
“The PFC is a brain region strongly involved in SB (1, 21, 22).”
Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats
Krebs-Thomson, K., & Geyer, M. A. (1994) · Psychopharmacology · doi:10.1007/bf02245219 · Cited by 29
LSD-induced alterations of investigatory responding in rats
Geyer, M. A., & Light, R. K. (1979) · Psychopharmacology · doi:10.1007/bf00491976 · Cited by 18
Cited by
Towards an understanding of psychedelic-induced neuroplasticity
Calder, A. E., & Hasler, G. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01389-z · Cited by 313
“However, one leading hypothesis suggests that the aforementioned AMPA receptor stimulation triggers a positive feedback loop: Stimulation of AMPA receptors may enhance BDNF secretion, which would stimulate TrkB receptors and mTOR, which in turn would stimulate further BDNF production and sustained AMPA activation [36,…”
BackgroundNeuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Aleksandrova, L. R., & Phillips, A. G. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.08.003 · Cited by 276
Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
van Elk, M., & Yaden, D. B. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104793 · Cited by 221
Psychedelics and Other Psychoplastogens for Treating Mental Illness.
Vargas, M. V., Meyer, R., Avanes, A. A., Rus, M., & Olson, D. E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.727117 · Cited by 166
Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity
Olson, D. E. (2022) · Biochemistry · doi:10.1021/acs.biochem.1c00812 · Cited by 129
Metadata
- Authors
- De Gregorio, D., Popic, J., Enns, J. P., Inserra, A., Skalecka, A., Markopoulos, A., Posa, L., Lopez-Canul, M., He, Q., Lafferty, C. K., Britt, J. P., Comai, S., Aguilar-Valles, A., Sonenberg, N., & Gobbi, G.
- Affiliations
- McGill University
- McGill University (CA)
- Vita-Salute San Raffaele University (IT)
- Carleton University
- Corresponding author
- Sonenberg, Nahum
- Gobbi, Gabriella
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2021-01-25
- Volume
- 118
- Issue
- 5
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC7865169
- OpenAlex
- W3121381676
- Cited by
- 139
- References
- 45
- Citations by year
- 2026: 19 · 2025: 25 · 2024: 29 · 2023: 40 · 2022: 15 · 2021: 11
- FWCI
- 16.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion, cc-by)
- eScholarship@McGill (McGill) (submittedVersion, cc-by)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- Funders
- Gouvernement du Canada | CIHR | Institute of Neurosciences, Mental Health and Addiction (436986)
- The Quebec Network for Suicide, Mood Disorders and Related Disorders (268065)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- lysergic acid diethylamide, LSD, social behavior, mTORC1, medial prefrontal cortex, 5-HT2A receptor, AMPA receptors, raptors, Akt/mTOR signaling, prosocial effects, psychedelics, autism spectrum disorder, social anxiety disorder
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Animals, Avoidance Learning, Behavior, Animal, Lysergic Acid Diethylamide, Male, Mice, Inbred C57BL, Synaptic Transmission, Neurons, Phosphorylation, Receptors, Serotonin, Social Behavior, Synapses, Receptors, N-Methyl-D-Aspartate, Prefrontal Cortex, Pyramidal Cells, Receptors, AMPA, Proto-Oncogene Proteins c-akt, Mice, TOR Serine-Threonine Kinases, Optogenetics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.